Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Angela DeMichele, MD, MSCE

Angela DeMichele, MD, MSCE Physician

Co-Leader, Breast Cancer Research Program Professor of Epidemiology in Biostatistics and Epidemiology Alan and Jill Miller Professor in Breast Cancer Excellence

Dr. DeMichele is employed by Penn Medicine.

About Dr. Angela DeMichele

Recognized by America's Top Doctors for 2017

Recognized in Philadelphia magazine's May 2018 Top Docs issue

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Medical Oncology

Programs & Centers:

Board Certification:

  • Medical Oncology, 1998

Clinical Expertise:

  • Breast Cancer

Description of Clinical Expertise

breast cancer, neoadjuvant therapy, menopausal symptoms related to cancer, cancer survivorship

Practice Locations and Appointments

  • Rena Rowan Breast Center

    Abramson Cancer Center Perelman Center for Advanced Medicine, West Pavilion, 3rd Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-7366 (PENN)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Washington University
Residency: Hospital of the University of Pennsylvania
Fellowship: University of Bologna School of Medicine
Fellowship: Hospital of the University of Pennsylvania


American Association of Cancer Research, National American Board of Internal Medicine, National American College of Epidemiology, National American College of Physicians, National American Society of Breast Disease, National American Society of Clinical Oncology, National Expedition Inspiration Fund for Breast Cancer Research, National Medical Advisory Board, Living Beyond Breast Cancer, National

Hospital Affiliation

Dr. DeMichele is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Description of Research Expertise:

breast cancer, biomarkers, clinical trials, pharmacogenetics, cytokines, host immunogenetics, cancer survivorship, molecular epidemiology

Selected Publications:

O'Shaughnessy Joyce, DeMichele Angela, Ma Cynthia X, Richards Paul, Yardley Denise A, Wright Gail Shaw, Kalinsky Kevin, Steis Ronald, Diab Sami, Kennealey Gerard, Geschwindt Ryan, Jiang Wei, Rugo Hope S: A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation. Breast cancer research and treatment 170 (3): 547-557,2018.

Banerjee Sagarika, Tian Tian, Wei Zhi, Shih Natalie, Feldman Michael D, Peck Kristen N, DeMichele Angela M, Alwine James C, Robertson Erle S: Distinct Microbial Signatures Associated With Different Breast Cancer Types. Frontiers in microbiology 9 : 951,2018.

Turner, N. C., Finn, R. S., Martin, M., Im, S. A., DeMichele, A., Ettl, J., Dieras, V., Moulder, S., Lipatov, O., Colleoni, M., Cristofanilli, M., Lu, D. R., Mori, A., Giorgetti, C., Iyer, S., Bartlett, C. H., Gelmon, K. A.: Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases Ann Oncol 29 (3): 669-680,2018.

Sturgeon, K. M., Hackley, R., Fornash, A., Dean, L. T., Laudermilk, M., Brown, J. C., Sarwer, D. B., DeMichele, A. M., Troxel, A. B., Schmitz, K. H.: Strategic recruitment of an ethnically diverse cohort of overweight survivors of breast cancer with lymphedema Cancer 124 (1): 95-104,2018.

O'Shaughnessy, J., DeMichele, A., Ma, C. X., Richards, P., Yardley, D. A., Wright, G. S., Kalinsky, K., Steis, R., Diab, S., Kennealey, G., Geschwindt, R., Jiang, W., Rugo, H. S.: A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation Breast Cancer Res Treat : 2018.

McAndrew, N., DeMichele, A.: Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer J Target Ther Cancer 7 (1): 52-69,2018.

Heymach, J., Krilov, L., Alberg, A., Baxter, N., Chang, S. M., Corcoran, R., Dale, W., DeMichele, A., Magid Diefenbach, C. S., Dreicer, R., Epstein, A. S., Gillison, M. L., Graham, D. L., Jones, J., Ko, A. H., Lopez, A. M., Maki, R. G., Rodriguez-Galindo, C., Schilsky, R. L., Sznol, M., Westin, S. N., Burstein, H.: Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology J Clin Oncol 36 (10): 1020-1044,2018.

Cochran JM, Chung SH, Leproux A, Baker WB, Busch DR, DeMichele AM, Tchou J, Tromberg BJ, Yodh AG: Longitudinal optical monitoring of blood flow in breast tumors during neoadjuvant chemotherapy Phys Med Biol 62 (12): 4637-4653,2017.

Homer MV, Charo LM, Natarajan L, Haunschild C, Chung K, Mao JJ, DeMichele AM, Su HI: Genetic variants of age at menopause are not related to timing of ovarian failure in breast cancer survivors Menopause 24 (6): 663-668,2017.

Maxwell KN, Soucier-Ernst D, Tahirovic E, Troxel AB, Clark C, Feldman M, Colameco C, Kakrecha B, Langer M, Lieberman D, Morrissette JJD, Paul MR, Pan TC, Yee S, Shih N, Carpenter E, Chodosh LA, DeMichele A: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer Breast Cancer Res Treat : 2017.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-104
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 349-5730
Patient appointments: 800-789-7366 (PENN)

Related Links